Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Molecular Screening of 28 Genes in Mexican Patients with Acute Myeloid Leukemia a Series of 70 Patients from the Instituto Nacional De Cancerologia, Mexico

Nidia Zapata, MD, Espinoza Ramiro, III, Eduardo Cervera, Judith Cruz, MD, Diana Arcos, MD, Juan Labardini, MD

Blood (2018) 132 (Supplement 1): 5197.

https://doi.org/10.1182/blood-2018-99-115300

Published: 2018

Journal Articles

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Ramiro Espinoza, MD, Manuel Aguilar Rodríguez, MD, Nidia P. Zapata, MD, Jorge Carlos Torres, Sr., Resident, Diana Berenice Nolasco, MD, Silvia Eugenia Alarcon Barrios, Eduardo Cervera, Myrna Candelaria, MD PhD, Valentin Lozano, Alejandro Sosa, Javier Espinoza, Magnolia Vieyra, Jorge Gutierrez, Luis Mario Sosa, Reynaldo González, Luis Oñate, Juan Labardini

Blood (2016) 128 (22): 5362.

https://doi.org/10.1182/blood.V128.22.5362.5362

Published: 2016

Journal Articles

Impact Of a Federal Program On response Rate & Survival, In a Cohort Of Patients With Diffuse Large B- Cell Lymphoma. Analysis In a Single National Reference Institution In Mexico

Myrna Candelaria, MD, PhD, Juan Labardini, MD, PhD, Ana Florencia Ramirez, Alejandro Aviles, MD, Enrique Estrada-Lobato, MD, Abelardo Meneses-Garcia, Md, PhD, Alejandro Mohar, MD, PhD

Blood (2013) 122 (21): 5608.

https://doi.org/10.1182/blood.V122.21.5608.5608

Published: 2013

Journal Articles

Hydralazine + Magnesium Valproate as Epigenetic Treatment for Myelodysplastic Syndrome (MDS). Preliminary Results of a Phase II Trial.

Myrna Candelaria, MD, Aquileo Herrera, MD, Juan Labardini, Sr., MD, Aurora Gonzalez-Fierro, Biol, Catalina Trejo-Becerril, MC, Erick de la Cruz-Hernandez, Dr, Brenda A la Torre-Talavera, Biol, Alfonso Duenas-Gonzalez, DR

Blood (2009) 114 (22): 1767.

https://doi.org/10.1182/blood.V114.22.1767.1767

Published: 2009

Journal Articles

Imatinib Alone (IA) Vs. Imatinib + Ara-C (IMAC): A Randomized Phase III Clinical Trial for the Treatment of Early Phase (EP) Chronic Myeloid Leukemia (CML) Ph+. Preliminary Report of Mexican Cooperative Leukemia Group (GRUMELA).

Rafael Hurtado Monroy, MD, Pablo Vargas-Viveros, MD, Eduardo Cervera, MD, Myrna Candelaria, MD, Alvaro Aguayo, MD, Emma Gallardo, MD, Eucario Leon, MD, Juan Labardini, MD, Ricardo Sosa, MD, Rogelio Paredes, MD, Fernando Romero, MD, Oscar Perez, MD, Omar Coronel-Ayala, MD

Blood (2004) 104 (11): 1015.

https://doi.org/10.1182/blood.V104.11.1015.1015

Published: 2004

Journal Articles

Hemolysis and Erythropoiesis. VI. A Comparative Study of the Utilization of Hemoglobin Iron and Transferrin Iron by the Erythropoietic Tissue

L. SANCHEZ-MEDAL, LORENZO DUARTE, JUAN LABARDINI

Blood (1970) 35 (5): 721–726.

https://doi.org/10.1182/blood.V35.5.721.721

Published: 1970

Journal Articles

Hemolysis and Erythropoiesis : I. Influence of Intraperitoneal Administration of Whole Hemolysates on the Recovery of Bled Dogs, as Measured by Changes in the Total Erythrocytic Volume.

LUIS SÁNCHEZ-MEDAL, M.D., JUAN LABARDINI, M.D., ALVAR LORÍA, M.S.

Blood (1963) 21 (5): 586–593.

https://doi.org/10.1182/blood.V21.5.586.586

Published: 1963

NARROW

Molecular Screening of 28 Genes in Mexican Patients with Acute Myeloid Leukemia a Series of 70 Patients from the Instituto Nacional De Cancerologia, Mexico

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Impact Of a Federal Program On response Rate & Survival, In a Cohort Of Patients With Diffuse Large B- Cell Lymphoma. Analysis In a Single National Reference Institution In Mexico

Hydralazine + Magnesium Valproate as Epigenetic Treatment for Myelodysplastic Syndrome (MDS). Preliminary Results of a Phase II Trial.

Imatinib Alone (IA) Vs. Imatinib + Ara-C (IMAC): A Randomized Phase III Clinical Trial for the Treatment of Early Phase (EP) Chronic Myeloid Leukemia (CML) Ph+. Preliminary Report of Mexican Cooperative Leukemia Group (GRUMELA).

Hemolysis and Erythropoiesis. VI. A Comparative Study of the Utilization of Hemoglobin Iron and Transferrin Iron by the Erythropoietic Tissue

Hemolysis and Erythropoiesis : I. Influence of Intraperitoneal Administration of Whole Hemolysates on the Recovery of Bled Dogs, as Measured by Changes in the Total Erythrocytic Volume.

Email alerts

ASH Publications

American Society of Hematology

Molecular Screening of 28 Genes in Mexican Patients with Acute Myeloid Leukemia a Series of 70 Patients from the Instituto Nacional De Cancerologia, Mexico

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Impact Of a Federal Program On response Rate & Survival, In a Cohort Of Patients With Diffuse Large B- Cell Lymphoma. Analysis In a Single National Reference Institution In Mexico

Hydralazine + Magnesium Valproate as Epigenetic Treatment for Myelodysplastic Syndrome (MDS). Preliminary Results of a Phase II Trial.

Imatinib Alone (IA) Vs. Imatinib + Ara-C (IMAC): A Randomized Phase III Clinical Trial for the Treatment of Early Phase (EP) Chronic Myeloid Leukemia (CML) Ph+. Preliminary Report of Mexican Cooperative Leukemia Group (GRUMELA).

Hemolysis and Erythropoiesis. VI. A Comparative Study of the Utilization of Hemoglobin Iron and Transferrin Iron by the Erythropoietic Tissue

Hemolysis and Erythropoiesis : I. Influence of Intraperitoneal Administration of Whole Hemolysates on the Recovery of Bled Dogs, as Measured by Changes in the Total Erythrocytic Volume.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only